Does Group Therapy Improve Resilience and Family Functioning Among Mothers of Children With Intellectual Disabilities?

July 30, 2026 updated by: Filiz ER, Sinop University

Effectiveness of a Group Therapy Intervention in Enhancing Resilience and Family Functioning Among Mothers of Children With Intellectual Disabilities: A Mixed-Methods Study

Abstract This study examined the effectiveness of a seven-week structured group therapy intervention designed to enhance the psychological resilience and family functioning of mothers of children with intellectual disabilities. A randomized controlled mixed-methods design was employed, involving an intervention group (n = 10) and a control group (n = 10). Participants were randomly assigned to study groups through a simple randomization procedure conducted by an independent academic who was not involved in participant recruitment, intervention delivery, or outcome assessment.

The intervention consisted of seven weekly face-to-face group sessions, each lasting approximately 90-120 minutes, and was delivered by a licensed social worker using a structured manualized protocol. The program integrated psychoeducation, cognitive-behavioral techniques, mindfulness-informed practices, self-compassion exercises, relaxation techniques, strengths-based approaches, and therapeutic group processes. Quantitative outcomes were assessed using the Resilience Scale for Adults (RSA) and the Family Assessment Device (FAD) at baseline, immediately after the intervention, and at a three-month follow-up. The quantitative component employed a two-way mixed-design repeated measures ANOVA to evaluate changes across assessment points. The qualitative component involved the collection of participants' verbal narratives and group interactions throughout the intervention, which were analyzed using reflexive thematic analysis and group process analysis to explore participants' experiences and therapeutic processes.

Study Overview

Status

Completed

Detailed Description

Detailed Description

Mothers of children with intellectual disabilities often experience substantial psychological, emotional, and social challenges associated with long-term caregiving responsibilities. These challenges may adversely affect psychological resilience, family functioning, and overall well-being. Although psychosocial interventions have demonstrated promising effects, evidence regarding structured group therapy programs specifically developed for this population remains limited.

The present study aimed to evaluate the effectiveness of a structured seven-session group therapy intervention in enhancing psychological resilience and family functioning among mothers of children with intellectual disabilities using a randomized controlled mixed-methods design. Eligible participants were randomly assigned to either an intervention group or a control group through a simple randomization procedure conducted by an independent academic who was not involved in participant recruitment, intervention delivery, or outcome assessment.

The intervention consisted of seven weekly face-to-face group sessions delivered by a licensed social worker. Each session lasted approximately 90-120 minutes and followed a structured manualized protocol integrating psychoeducation, cognitive-behavioral techniques, mindfulness-informed practices, self-compassion exercises, relaxation techniques, strengths-based approaches, and therapeutic group processes. Session topics included building trust and group cohesion, emotional awareness and expression, acceptance and stress management, cognitive reframing and family adaptation, self-compassion, awareness of personal needs and social support, and integration of therapeutic gains into daily life.

Participants allocated to the control group received no intervention during the study period. Quantitative outcomes were assessed using the Resilience Scale for Adults (RSA) and the Family Assessment Device (FAD) at baseline, immediately after the intervention, and three months after completion of the intervention.

To complement the quantitative component, qualitative data were collected throughout the intervention from participants' verbal narratives and group interactions. These data were analyzed using reflexive thematic analysis and group process analysis to explore participants' experiences, perceived changes, and therapeutic processes.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • Female adults aged 18 years or older.
  • Mothers who were the primary caregivers of a child diagnosed with intellectual disability according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
  • Had provided continuous care for the child with intellectual disability for at least five years.
  • Able to communicate in Turkish and participate in group sessions.
  • Voluntarily agreed to participate in the study and provided written informed consent.

Exclusion Criteria

  • Presence of a chronic physical or mental illness severe enough to interfere with participation in the group intervention or group interaction.
  • Inability or unwillingness to participate throughout the intervention.
  • Withdrawal of informed consent at any stage of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group Therapy Intervention
Participants received a structured seven-session face-to-face group therapy intervention delivered once weekly by a licensed social worker. Each session lasted approximately 90-120 minutes and incorporated psychoeducation, cognitive-behavioral techniques, mindfulness-informed practices, self-compassion exercises, relaxation techniques, strengths-based approaches, and therapeutic group processes.

Intervention Description Participants assigned to the intervention group received an eight-session manualized group therapy program, delivered once weekly in face-to-face group sessions by a licensed social worker. Each session lasted approximately 90-120 minutes and followed a structured protocol designed to enhance resilience and family functioning among mothers of children with intellectual disabilities.

The intervention integrated psychoeducation, cognitive-behavioral techniques, mindfulness-based practices, relaxation exercises, self-compassion training, strengths-based approaches, and group process interventions. The sessions addressed (1) group cohesion and psychological safety, (2) emotional awareness and expression, (3) acceptance and stress management, (4) cognitive reframing and family adaptation, (5) self-compassion and realistic expectations, (6) social support and awareness of personal needs, (7) integration of therapeutic gains into daily life, and program review, evalua

No Intervention: Control Group
Participants assigned to the control group received no intervention during the study period and completed the same outcome assessments as the intervention group at baseline, post-intervention, and three-month follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resilience Scale for Adults (RSA)
Time Frame: Baseline, Week 7, and Week 19
Psychological resilience was assessed using the Resilience Scale for Adults (RSA), a 33-item self-report instrument that evaluates six domains of resilience: perception of self, perception of future, structured style, social competence, family cohesion, and social resources. Higher total scores indicate greater psychological resilience.
Baseline, Week 7, and Week 19

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family Assessment Device (FAD)
Time Frame: Baseline, Week 7, and Week 19
Family functioning was assessed using the Family Assessment Device (FAD), a 60-item self-report instrument based on the McMaster Model of Family Functioning. The scale evaluates problem solving, communication, roles, affective responsiveness, affective involvement, behavior control, and general functioning. Lower scores indicate healthier family functioning, whereas higher scores indicate greater family dysfunction.
Baseline, Week 7, and Week 19

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2023

Primary Completion (Actual)

February 8, 2024

Study Completion (Actual)

May 20, 2024

Study Registration Dates

First Submitted

July 27, 2026

First Submitted That Met QC Criteria

July 30, 2026

First Posted (Actual)

July 31, 2026

Study Record Updates

Last Update Posted (Actual)

July 31, 2026

Last Update Submitted That Met QC Criteria

July 30, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to participant confidentiality and the absence of consent for public data sharing.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe